US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 282 actively recruiting studies with Virginia sites out of 282 registered in total. The busiest research areas in Virginia are Breast Cancer, Colorectal Cancer, Endometrial Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Virginia, Virginia Commonwealth University. By stage, Virginia trials break down as Phase 1 (60), Phase 2 (93), Phase 3 (86), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
282
Recruiting Now
282
← Back to US Map
Top Conditions in Virginia
Breast Cancer (15)Colorectal Cancer (10)Endometrial Cancer (9)Ovarian Cancer (8)Acute Myeloid Leukemia (7)Non-Small Cell Lung Cancer (7)Advanced Solid Tumor (6)Non-small Cell Lung Cancer (6)Prostate Cancer (5)Metastatic Breast Cancer (4)NSCLC (4)Obesity (3)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 282 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 282. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT05245695 N/A
Recruiting
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affe...
Condition
Endometriosis
Enrollment
1,200 pts
Location
United States
Sponsor
Aspira Women's Health
View Trial →
NCT06563895 Phase 3
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) S...
Condition
Amyloidosis
Enrollment
587 pts
Location
United States, Argentina, Australia
Sponsor
Eidos Therapeutics, a BridgeBi
View Trial →
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
View Trial →
NCT06853145 EARLY_Phase 1
Recruiting
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
6 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07502495 Phase 2
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Ach...
Condition
Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Biomea Fusion Inc.
View Trial →
NCT06370000 Phase 4
Recruiting
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AM...
Condition
Acute Myeloid Leukemia
Enrollment
12 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT06795412 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid T...
Condition
Advanced Solid Tumors
Enrollment
220 pts
Location
United States, France, Spain
Sponsor
Pyxis Oncology, Inc
View Trial →
NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
View Trial →
NCT07012031 Phase 1, Phase 2
Recruiting
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locall...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
37 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06911424 Phase 3
Recruiting
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Condition
Bacterial Conjunctivitis
Enrollment
400 pts
Location
United States
Sponsor
Baxis Pharmaceuticals, Inc.
View Trial →
NCT06619990 Phase 1, Phase 2
Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Coliti...
Condition
Ulcerative Colitis (UC)
Enrollment
270 pts
Location
United States, Australia, Bulgaria
Sponsor
Xencor, Inc.
View Trial →
NCT04986423 Phase 2
Recruiting
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castrat...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
200 pts
Location
United States, China
Sponsor
Zenith Epigenetics
View Trial →
NCT05873686 Phase 1
Recruiting
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Condition
Advanced Solid Tumor
Enrollment
140 pts
Location
United States, United Kingdom
Sponsor
Nuvectis Pharma, Inc.
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06607627 Phase 3
Recruiting
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With ACh...
Condition
Generalized Myasthenia Gravis
Enrollment
12 pts
Location
United States, Brazil, Japan
Sponsor
Alexion Pharmaceuticals, Inc.
View Trial →
NCT07225751 N/A
Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Asses...
Condition
Ankle Arthrodesis or Arthroplasty
Enrollment
126 pts
Location
United States
Sponsor
Kuros Biosurgery AG
View Trial →
NCT05061550 Phase 2
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Condition
Non-small Cell Lung Cancer
Enrollment
630 pts
Location
United States, Belgium, Canada
Sponsor
AstraZeneca
View Trial →
NCT03526835 Phase 1, Phase 2
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Condition
Advanced/Metastatic Solid Tumors
Enrollment
523 pts
Location
United States, Belgium, France
Sponsor
Merus B.V.
View Trial →
NCT07185997 Phase 3
Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigato...
Condition
Non-Small-Cell Lung Cancer
Enrollment
480 pts
Location
United States, Australia, Canada
Sponsor
ArriVent BioPharma, Inc.
View Trial →
NCT05475925 Phase 1, Phase 2
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotox...
Condition
LGLL - Large Granular Lymphocytic Leukemia
Enrollment
200 pts
Location
United States, Australia, France
Sponsor
Dren Bio
View Trial →
NCT04905017 N/A
Recruiting
Trisol System EFS Study
Condition
Tricuspid Regurgitation
Enrollment
30 pts
Location
United States
Sponsor
Trisol Medical
View Trial →
NCT05892614 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patie...
Condition
Interstitial Lung Disease
Enrollment
25 pts
Location
United States
Sponsor
aTyr Pharma, Inc.
View Trial →
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06707610 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitum...
Condition
Advanced Cancer
Enrollment
234 pts
Location
United States, Australia
Sponsor
Shanghai Allink Biotherapeutic
View Trial →
NCT07354724 Phase 1
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952...
Condition
Late-onset Pompe Disease
Enrollment
32 pts
Location
United States
Sponsor
Denali Therapeutics Inc.
View Trial →
Page 2 of 12 — 282 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology